Fact CheckerSign in

NCT06383104Completed

Myofascial Techniques and Proprioceptive Neuromuscular Facilitation in Patients With Systemic Lupus Erythematosus.

Combination of Myofascial Techniques and Proprioceptive Neuromuscular Facilitation in the Clinical and Functional Improvement of Patients With Systemic Lupus Erythematosus. Randomised Clinical Study

Source: ClinicalTrials.gov · Last updated 27 Mar 2025

Brief summary (registry, in English)

Introduction. Systemic lupus erythematosus is an autoimmune disease. The musculoskeletal system is affected in 90% of patients. The most common manifestations are myalgias, arthralgias and arthritis. Objective. To analyse the efficacy of an intervention using myofascial techniques and proprioceptive neuromuscular facilitation in patients with systemic lupus erythematosus. Methods. Randomised clinical study with 20 patients with systemic lupus erythematosus, randomised to an experimental and control group. The intervention will last 4 weeks, with a periodicity of 2 weekly sessions of 50 minutes each. The intervention of the experimental group will consist of a protocol using myofascial and proprioceptive neuromuscular facilitation techniques. Expected results. Improvement of knee and ankle pain intensity, functional capacity, basic mobility skills, strength, balance, agility and fatigue.

Status (registry)
Completed
Study type
Interventional
Enrollment
17 (actual)
First submitted
18 Apr 2024
Start date
22 Apr 2024
Primary completion date
28 May 2024
Lead sponsor
Universidad Católica San Antonio de Murcia
Diseases
Lupus (SLE)
NCT number
NCT06383104

What you commit to

  • Study type: Interventional
  • Participants enrolled: 17
  • From 22 Apr 2024 to the primary completion date, 28 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients with fever or acute phlebitis.
  • Patients with recent lower limb fractures
  • Amputees and people with neurological or cognitive impairments that prevent them from correctly understanding the questionnaires and performing the guided techniques.

Who the study is looking for

  • Subjects over 18 years of age
  • With a medical diagnosis of systemic lupus erythematosus
  • Who sign the informed consent form.

Age in the registry: 18 years to 55 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universidad Católica San Antonio, Murcia
Coordinator of this site? Confirm its status
MurciaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.